LIFECORE BIOMEDICAL INC (LFCR)

US5147661046 - Common Stock

7.24  +0.17 (+2.4%)

After market: 7.2393 0 (-0.01%)

LIFECORE BIOMEDICAL INC

NASDAQ:LFCR (12/20/2024, 8:22:07 PM)

After market: 7.2393 0 (-0.01%)

7.24

+0.17 (+2.4%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS SubIndustryLife Sciences Tools & Services
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%-50.29%
Sales Q2Q%0.75%
CRS89.08
6 Month44.22%
Overview
Earnings (Last)10-04 2024-10-04/bmo
Earnings (Next)N/A N/A
Ins Owners10.59%
Inst OwnersN/A
Market Cap266.65M
Shares36.83M
PE144.8
Fwd PEN/A
Dividend YieldN/A
Analysts77.78
Short Float %6.72%
Short Ratio13.15
IPO02-15 1996-02-15
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

LFCR Daily chart

Company Profile

Lifecore Biomedical, Inc. is a contract development and manufacturing organization, which engages in the provision of differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. The company is headquartered in Chaska, Minnesota and currently employs 524 full-time employees. The firm designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The firm offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. The company is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The firm uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Company Info

LIFECORE BIOMEDICAL INC

3515 Lyman Boulevard

Chaska MINNESOTA

P: 19523684300

Employees: 524

Website: https://www.lifecore.com/

LFCR News

News Image2 days ago - Lifecore Biomedical, Inc.Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025

Webcast Scheduled for Thursday, January 2 at 4:30 p.m. Eastern

News Image2 days ago - Lifecore Biomedical, Inc.Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025

Webcast Scheduled for Thursday, January 2 at 4:30 p.m. Eastern...

News Image2 days ago - Lifecore Biomedical, Inc.Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
News Image2 days ago - Lifecore Biomedical, Inc.Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment

Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of NRS-033 for Planned Phase 2 Trial Lifecore to...

News Image25 days ago - Lifecore Biomedical, Inc.Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO
News Image25 days ago - Lifecore Biomedical, Inc.Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO

Three-Year Term Extension Combined with Simplification and Reduction of Interest Rates Helps Further Strengthen Company’s Balance Sheet and Overall...

LFCR Twits

Here you can normally see the latest stock twits on LFCR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example